Related Experiment Video
Updated: Oct 9, 2025

A Protocol for Comprehensive Assessment of Bulbar Dysfunction in Amyotrophic Lateral Sclerosis ALS
Published on: February 21, 2011
Juvenile Amyotrophic Lateral Sclerosis: A Review
Tanya Lehky1, Christopher Grunseich2
1EMG Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892, USA.
Juvenile amyotrophic lateral sclerosis (JALS) involves genetic mutations in 40% of cases, with FUS, SETX, and ALS2 being most common. Prognosis and distinct clinical features depend on specific gene mutations.
Area of Science:
- Neurology
- Genetics
- Pediatric Disorders
Background:
- Juvenile amyotrophic lateral sclerosis (JALS) is a rare motor neuron disease with onset before age 25.
- Genetic factors are implicated in approximately 40% of JALS cases.
Purpose of the Study:
- To review existing literature on JALS and its associated gene mutations.
- To identify common genetic mutations and their inheritance patterns in JALS.
Main Methods:
- Literature review of JALS and associated gene mutations.
- Analysis of genetic inheritance patterns (autosomal recessive, autosomal dominant).
Main Results:
- The most frequent gene mutations linked to JALS are FUS, SETX, and ALS2.
- Familial JALS often shows autosomal recessive inheritance, while SETX mutations can be autosomal dominant.
- Disease progression and clinical presentation vary based on specific genetic mutations.
Conclusions:
- Early-onset motor neuron disorders (before age 25) warrant genetic mutation screening.
- Identifying specific gene mutations and inheritance patterns aids in predicting JALS prognosis and clinical course.
Related Concept Videos
Parkinson's Disease: Overview
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
Satellite Stem Cells and Muscular Dystrophy
Lysosomal Hydrolases
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...

